Hepa-Merz® can be used for the treatment of concomitant and secondary diseases. These are diseases that develop because the liver’s function to detoxify the body is impaired – e.g. in patients with liver cirrhosis and with symptoms of latent and manifest hepatic encephalopathy.
Strategies in the treatment of HE – the role of Hepa-Merz®
Formulations and dosages
Hepa-Merz® is available both as an infusion concentrate (mainly for inpatients in hospitals) and as granules. The granules are packed in portions in small bags and can be dissolved e.g. in a glass of water, tea or juice and taken with or after meals.
Hepa-Merz® granules are available in two dosages:
Hepa-Merz® Granules 3000 contain 3 grams of L-ornithine L-aspartate per sachet.
Recommended dosage: up to 3x daily 1 – 2 sachets
packs of 30, 50 and 100 bags
Hepa-Merz® Granules 6000 contain 6 grams of L-ornithine L-aspartate per sachet.
Recommended dosage: up to 3x daily 1 sachet
packs of 50 and 100 bags
Hepa-Merz® Infusion concentrate
Package sizes: 5x 10ml or 10x 10ml.
1 ampoule of 10ml concentrate contains 5g of LOLA in water for solution in 500ml NaCl.
Unless otherwise prescribed up to 4 amps/day pre-coma or coma: up to 8 amp/24 h, depending on severity of condition.
Infusion rate: 1 ampoule (5g LOLA) per hour
